All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @alphagenics on TikTok · 39s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @alphagenics's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hey folks, this was me at 230 pounds, May of 2024.
  2. 0:06After three months of having my testosterone levels
  3. 0:09dialed in and semi-glutide,
  4. 0:12this is how I looked after that.
  5. 0:14Then I kept up with the working out,
  6. 0:17all that good stuff, keeping my levels optimized,
  7. 0:20continued on semi-glutide for a few more months,
  8. 0:23about two or three, and this is how I pretty much turned up.
  9. 0:27Stopping the semi-glutide, I continued working out
  10. 0:30in all the good habits that I've developed TRT,
  11. 0:33and now I just sustained a whole new person,
  12. 0:36I'm just a whole new person now, it is amazing.

@alphagenics's TRT and semaglutide claims, fact-checked

AlphaGenics

TikTok creator

14.2K viewsWatch on TikTok

Quick answer

The creator describes a multi-month protocol combining testosterone replacement therapy with semaglutide, beginning at 230 pounds, followed by discontinuation of semaglutide with continued TRT and lifestyle maintenance. This sequence, hormone normalization plus GLP-1 agonist plus behavioral change, reflects a plausible clinical approach for men with confirmed hypogonadism and obesity, though the individual results shown cannot be extrapolated as typical outcomes. Weight maintenance after GLP-1 cessation, as he describes, depends heavily on the sustained behavioral habits he references, which is consistent with current evidence from the STEP 4 trial.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @alphagenics's TRT and semaglutide claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@alphagenics's TRT and semaglutide claims, fact-checked" from AlphaGenics. We read the clip as a TRT social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes a multi-month protocol combining testosterone replacement therapy with semaglutide, beginning at 230 pounds, followed by discontinuation of semaglutide with continued TRT and lifestyle maintenance.

The reason this review is not generic is the source wording and the canonical claim label "trt i woke up one day and decided to take my life back i combin." In this clip, the useful excerpt is: "Hey folks, this was me at 230 pounds, May of 2024." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The STEP 4 trial (Rubino et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes a multi-month protocol combining testosterone replacement therapy with semaglutide, beginning at 230 pounds, followed by discontinuation of semaglutide with continued TRT and lifestyle maintenance.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes a multi-month protocol combining testosterone replacement therapy with semaglutide, beginning at 230 pounds, followed by discontinuation of semaglutide with continued TRT and lifestyle maintenance. This sequence, hormone normalization plus GLP-1 agonist plus behavioral change, reflects a plausible clinical approach for men with confirmed hypogonadism and obesity, though the individual results shown cannot be extrapolated as typical outcomes. Weight maintenance after GLP-1 cessation, as he describes, depends heavily on the sustained behavioral habits he references, which is consistent with current evidence from the STEP 4 trial.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks with semaglutide, making three-to-six month visible changes plausible but individual results vary substantially.
  • The STEP 4 trial (Rubino et al., 2021, JAMA) found that two-thirds of weight lost on semaglutide was regained within one year of stopping it without lifestyle intervention, making the creator's habit-maintenance framing clinically important, not just motivational.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks with semaglutide, making three-to-six month visible changes plausible but individual results vary substantially.
  • The STEP 4 trial (Rubino et al., 2021, JAMA) found that two-thirds of weight lost on semaglutide was regained within one year of stopping it without lifestyle intervention, making the creator's habit-maintenance framing clinically important, not just motivational.
  • TRT is a treatment for diagnosed hypogonadism, not a general optimization tool. Two fasting morning testosterone draws are the standard diagnostic requirement before a legitimate prescription.
  • Testosterone cypionate takes six to eight weeks to stabilize in serum and semaglutide requires four to eight weeks of dose titration, meaning 'almost immediate' results claims should be viewed skeptically from a pharmacokinetic standpoint.
  • Compounded semaglutide is not equivalent to brand-name Ozempic or Wegovy in terms of formulation standards, dosing precision, or regulatory oversight. This distinction matters when evaluating telehealth-accessed options.
  • Corona et al. (2013, European Journal of Endocrinology) found TRT in hypogonadal men reduced fat mass by roughly 1.5 to 2 kg over 12 months, a real but modest effect that depends on confirmed deficiency.
  • Testosterone normalization in hypogonadal men has documented effects on mood and motivation (Zarrouf et al., 2009, Journal of Psychiatric Practice), which may indirectly improve exercise adherence and dietary behavior rather than directly burning fat.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @alphagenics actually say?

The creator shared a before-and-after story: 230 pounds in May 2024, three months of testosterone optimization plus semaglutide, continued workouts, then stopping semaglutide while maintaining TRT and healthy habits. The summary claim is that he became "a whole new person." No numbers beyond his starting weight. No labs mentioned. No doses discussed. This is a personal testimonial, not a clinical report, and it should be read as exactly that.

To his credit, he repeatedly acknowledged that the drugs are not doing the work alone. "You still have to put in work," he says in the caption. That caveat matters more than most people realize, and it is one of the more honest things a TRT/GLP-1 creator has said on this platform.

Does the science back this up?

Yes, with important caveats. The combination of testosterone therapy and a GLP-1 receptor agonist like semaglutide is not fringe medicine. There is legitimate mechanistic overlap here worth understanding before you assume this is just good marketing.

On testosterone: a 2013 meta-analysis by Corona et al. in the European Journal of Endocrinology found that TRT in hypogonadal men was associated with significant reductions in fat mass and increases in lean body mass. The effect size was modest on its own, roughly 1.5 to 2 kg of fat loss over 12 months in most trials, which means testosterone alone is not a transformation drug.

On semaglutide: the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed a mean weight loss of 14.9% body weight over 68 weeks in non-diabetic adults with obesity. That is a meaningful and reproducible effect. Three months of semaglutide, combined with caloric deficit and exercise, could plausibly produce substantial visible change.

The combination? Less studied. There are no large RCTs specifically on TRT plus semaglutide for body composition in otherwise healthy men as of early 2025. The mechanistic rationale is reasonable, but the creator's timeline and results are his own, not a guaranteed outcome for anyone else.

What did they get wrong (or right)?

He got more right than wrong, which is not what you usually see in this content category. The "results almost immediately" line in the caption is where things get slippery. Semaglutide typically takes four to eight weeks to reach therapeutic dosing due to the titration schedule. Testosterone cypionate, a common TRT form, takes six to eight weeks to stabilize in serum levels. "Almost immediately" does not match the pharmacokinetics.

What he got right is the sustainability framing. He stopped semaglutide and maintained his results through continued TRT and habits. Research on GLP-1 cessation is genuinely concerning here. The STEP 4 trial (Rubino et al., 2021, JAMA) showed participants regained about two-thirds of lost weight within one year of stopping semaglutide without continued lifestyle intervention. His emphasis on built habits as the retention mechanism is actually the correct clinical answer.

He also did not claim TRT cured anything, did not prescribe a dose, and did not promise anyone else his results. That puts him above average for this content category.

What should you actually know?

A few things that the video, understandably, does not cover. First, TRT is a treatment for hypogonadism, a diagnosed medical condition, not a general performance upgrade. Prescribing it requires confirmed low testosterone via blood work, typically two morning fasted draws. Using it without deficiency is not the same clinical scenario the creator described, and the risk-benefit math changes significantly.

Second, semaglutide access through telehealth has expanded rapidly, but compounded semaglutide is not the same as brand-name Ozempic or Wegovy. Formulation, dosing accuracy, and sterility standards differ. This distinction matters for both safety and efficacy expectations.

Third, the psychological component of a transformation like this is real and rarely discussed. Testosterone normalization in hypogonadal men has documented effects on motivation and mood (Zarrouf et al., 2009, Journal of Psychiatric Practice). Feeling better makes you more likely to exercise and make better food choices. The drug does not lift the weights. But feeling like yourself again can make you want to.

If you are considering either therapy, get your labs done first. Know your baseline. A responsible provider will not start you on either without them.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

AlphaGenics · TikTok creator

14.2K views on this video

I woke up one day and decided to take my life back. I combined TRT and semaglutide with working out and eating right and I saw results almost immediately. Keep in mind you still have to put in work wh

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) showed?

The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks with semaglutide, making three-to-six month visible changes plausible but individual results vary substantially.

What does the video say about the step 4 trial (rubino et al., 2021, jama) found?

The STEP 4 trial (Rubino et al., 2021, JAMA) found that two-thirds of weight lost on semaglutide was regained within one year of stopping it without lifestyle intervention, making the creator's habit-maintenance framing clinically important, not just motivational.

What does the video say about trt?

TRT is a treatment for diagnosed hypogonadism, not a general optimization tool. Two fasting morning testosterone draws are the standard diagnostic requirement before a legitimate prescription.

What does the video say about testosterone cypionate takes six to eight weeks to stabilize in?

Testosterone cypionate takes six to eight weeks to stabilize in serum and semaglutide requires four to eight weeks of dose titration, meaning 'almost immediate' results claims should be viewed skeptically from a pharmacokinetic standpoint.

What does the video say about compounded semaglutide?

Compounded semaglutide is not equivalent to brand-name Ozempic or Wegovy in terms of formulation standards, dosing precision, or regulatory oversight. This distinction matters when evaluating telehealth-accessed options.

What does the video say about corona et al. (2013, european journal of endocrinology) found trt?

Corona et al. (2013, European Journal of Endocrinology) found TRT in hypogonadal men reduced fat mass by roughly 1.5 to 2 kg over 12 months, a real but modest effect that depends on confirmed deficiency.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by AlphaGenics, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.